Kanamycin is an aminoglycoside antibiotic used as parenteral therapy for serious susceptible bacterial infections. Labeling emphasizes toxicity monitoring (ototoxicity, nephrotoxicity, neurotoxicity) and antimicrobial stewardship to prevent resistance. It is a human prescription antibacterial product with established but safety-limited use.
GC Biopharma said a review paper in Human Vaccines & Therapeutics analyzed more than 40 studies on its MAV/06 varicella vaccine strain. The paper summarized 30 years of data showing 99-100% neutralizing antibody rates and adverse event incidence of 0.41 to 0.57 cases per 100,000 doses.
CDC and FDA are investigating a multistate outbreak of extensively drug-resistant Salmonella Newport infections linked to Rosabella brand moringa powder capsules, with seven people sickened across seven states and three requiring hospitalization.
